ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.046,09
0,25%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Neurocrine Biosciences Inc (NBIX)

  7. Neurocrine Biosciences Inc (NBIX) News

NBIX Neurocrine Biosciences Inc

140,71
0,88 (0,63%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Neurocrine Biosciences Inc NBIX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,88 0,63% 140,71 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
140,90 139,23 141,88 140,71 139,83
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202419:15PRNUSNeurocrine Biosciences Presented CAHtalyst™ Pediatric Study..
01.5.202413:00PRNUSNeurocrine Biosciences Reports First Quarter 2024 Financial..
30.4.202423:12PRNUSNeurocrine Biosciences Announces U.S. FDA Approval of..
24.4.202414:30PRNUSNeurocrine Biosciences Launches WHAT THE C@H?! Educational..
23.4.202413:00PRNUSNeurocrine Biosciences Reports Positive Phase 2 Data for..
16.4.202422:01GLOBESentia Medical Sciences and Neurocrine Biosciences Extend..
10.4.202422:01PRNUSNeurocrine Biosciences Announces Conference Call and Webcast..
03.4.202414:30PRNUSNeurocrine Biosciences Announces First-Patient Dosed in..
28.3.202413:30PRNUSNeurocrine Biosciences Announces Initiation of Phase 1..
11.3.202421:01PRNUSNeurocrine Biosciences to Participate at Virtual Investor..
08.3.202422:22EDGAR2Form 144 - Report of proposed sale of securities
08.3.202422:22EDGAR2Form 144 - Report of proposed sale of securities
01.3.202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:29EDGAR2Form 144 - Report of proposed sale of securities
27.2.202422:01PRNUSNeurocrine Biosciences to Participate at Investor..
22.2.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:33EDGAR2Form 144 - Report of proposed sale of securities
15.2.202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:34EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:34EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:34EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:33EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:20EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:20EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:19EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:19EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:18EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:17EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:17EDGAR2Form 144 - Report of proposed sale of securities
09.2.202423:29EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09.2.202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
NBIX
Neurocrine Biosciences
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten